Months after cancer drug trial, Merus agrees to be bought at 41% premium

1 month ago 56
Merus agreed to be bought for a 41% premium, months after a positive trial of a cancer drug.
Read Entire Article
  1. Homepage
  2. category-label-
  3. Months after cancer drug trial, Merus agrees to be bought at 41% premium

Related

Gold has a shot at $5,000 if investors rekindle this popular trade

Gold has a shot at $5,000 if investors rekindle this popular...

45 minutes ago 0
Meta’s stock is the new ‘Magnificent Seven’ doormat. Should you buy the dip?

Meta’s stock is the new ‘Magnificent Seven’ doormat. Should ...

45 minutes ago 0
Trade wars are dying down, but the U.S. economy is still licking its wounds

Trade wars are dying down, but the U.S. economy is still lic...

45 minutes ago 0

Trending

Popular

Trump could give automakers relief from Nexperia chip shortage

Trump could give automakers relief from Nexperia chip shorta...

6 days ago 79
Musk unveils X Chat, a messenger with encryption ‘similar to Bitcoin’

Musk unveils X Chat, a messenger with encryption ‘similar to...

6 days ago 79
Home buyers are being left in limbo as the shutdown delays mortgage and insurance applications

Home buyers are being left in limbo as the shutdown delays m...

6 days ago 66
New Hampshire Senate stalls crypto mining deregulation bill after split vote

New Hampshire Senate stalls crypto mining deregulation bill ...

6 days ago 56
Bitcoin's 4-year cycle isn't dead, expect a 70% drop next downturn: VC

Bitcoin's 4-year cycle isn't dead, expect a 70% drop next do...

6 days ago 55
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Tayedi Search engine 2025. All rights are reserved